Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Federal Trade Commission
Accenture
Mallinckrodt
Cipla
Farmers Insurance
Deloitte
Merck
UBS

Generated: August 15, 2018

DrugPatentWatch Database Preview

Claims for Patent: 8,440,170

« Back to Dashboard

Summary for Patent: 8,440,170
Title:Orally disintegrating tablets with speckled appearance
Abstract: Orally disintegrating tablets containing colored granules of a water-soluble sugar which give them a speckled appearance are described. The orally disintegrating tablets with speckled appearance are readily and easy identifiable by physicians, nurses and patients.
Inventor(s): Stroppolo; Federico (Mezzovico, CH), Ardalan; Shahbaz (Mezzovico, CH)
Assignee: Alpex Pharma SA (Mezzovico, CH)
Application Number:12/811,737
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,440,170
Patent Claims: 1. An orally disintegrating tablets with speckled appearance comprising (a) speckles comprising colored granules of a water-soluble sugar, and (b) a pharmaceutically acceptable carrier.

2. The orally disintegrating tablets according to claim 1 wherein the water-soluble sugar is selected from the group consisting of sucrose and polyalcohols.

3. The orally disintegrating tablets according to claim 2 wherein the water-soluble sugar is selected from the group consisting of sucrose, sorbitol, mannitol, xylitol, and fructose.

4. The orally disintegrating tablets according to claim 3 wherein the water-soluble sugar is mannitol.

5. The orally disintegrating tablets according to claim 1 wherein the colored granules have a particle size from about 10 .mu.m to about 1200 .mu.m.

6. The orally disintegrating tablets according to claim 5 wherein the colored granules have a particle size from about 200 .mu.m to about 800 .mu.m.

7. The orally disintegrating tablets according to claim 6 wherein the colored granules have a particle size from about 300 .mu.m to about 500 .mu.m.

8. The orally disintegrating tablets according to claim 1 wherein the colored granules are present in an amount from about 0.1% w/w to about 50% w/w per tablet.

9. The orally disintegrating tablets according to claim 1 wherein the colored granules are present in an amount from about 1% w/w to about 30% w/w.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Baxter
Deloitte
Argus Health
QuintilesIMS
Cerilliant
Julphar
McKinsey
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.